Cargando…
First Trimester Dexamethasone Treatment Is Not Associated With Alteration in Resting-state Connectivity at Adolescent or Adult Age
CONTEXT: Prenatal treatment with dexamethasone (DEX) has been used to prevent virilization in females at risk of congenital adrenal hyperplasia (CAH). Both affected and unaffected girls, as well boys, are treated until the genotype and sex of the fetus is known (gestational weeks 10-12). After that,...
Autores principales: | Messina, Valeria, van’t Westeinde, Annelies, Padilla, Nelly, Lajic, Svetlana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516042/ https://www.ncbi.nlm.nih.gov/pubmed/35882216 http://dx.doi.org/10.1210/clinem/dgac426 |
Ejemplares similares
-
Changes in resting-state functional connectivity in patients with congenital adrenal hyperplasia
por: Messina, Valeria, et al.
Publicado: (2022) -
First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age
por: van’t Westeinde, Annelies, et al.
Publicado: (2020) -
First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults
por: van’t Westeinde, Annelies, et al.
Publicado: (2020) -
Brain structure in autoimmune Addison’s disease
por: van’t Westeinde, Annelies, et al.
Publicado: (2022) -
An update on the long-term outcomes of prenatal dexamethasone treatment in congenital adrenal hyperplasia
por: van’t Westeinde, Annelies, et al.
Publicado: (2023)